Nociceptin inhibits capsaicin-induced bronchoconstriction in isolated guinea pig lung. 2000

M R Corboz, and M A Rivelli, and R W Egan, and D Tulshian, and J Matasi, and A B Fawzi, and L Benbow, and A Smith-Torhan, and H Zhang, and J A Hey
Allergy, Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, NJ 07033, USA. michel.corboz@spcorp.com

The isolated perfused guinea pig lung was used to investigate the effect of nociceptin against bronchoconstriction elicited by endogenous and exogenous tachykinins. The opioid receptor-like 1 (ORL1) receptor agonist, nociceptin/orphanin FQ (0.001-1 microM) produced a dose-related inhibition of the capsaicin-induced bronchoconstriction (10(-5)-10(3) microg) in isolated guinea pig lung (P<0.05), a response mediated by the release of endogenous tachykinins from lung sensory nerves. The new ORL1 receptor antagonist 1-[(3R, 4R)-1-Cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1, 3-dihydro-2H-benzimidazol-2-one (J-113397) (0.3 microM) significantly blocked the inhibitory effect of nociceptin/orphanin FQ (0.01 microM) on capsaicin-induced bronchoconstriction, whereas the non-selective opioid receptor antagonist naloxone (1 microM) had no effect. Nociceptin/orphanin FQ (1 microM) did not affect the bronchoconstriction induced exogenously by the tachykinin NK2 receptor agonist neurokinin A. In conclusion, the present data provide evidence that nociceptin inhibits capsaicin-evoked tachykinin release from sensory nerve terminals in guinea pig lung by a prejunctional mechanism. This inhibitory action occurs independently from activation of opioid receptors. The present study also indicates that J-113397 is a potent ORL1 receptor antagonist.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D009270 Naloxone A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. MRZ 2593-Br,MRZ-2593,Nalone,Naloxon Curamed,Naloxon-Ratiopharm,Naloxone Abello,Naloxone Hydrobromide,Naloxone Hydrochloride,Naloxone Hydrochloride Dihydride,Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Narcan,Narcanti,Abello, Naloxone,Curamed, Naloxon,Dihydride, Naloxone Hydrochloride,Hydrobromide, Naloxone,Hydrochloride Dihydride, Naloxone,Hydrochloride, Naloxone,MRZ 2593,MRZ 2593 Br,MRZ 2593Br,MRZ2593,Naloxon Ratiopharm
D009292 Narcotic Antagonists Agents inhibiting the effect of narcotics on the central nervous system. Competitive Opioid Antagonist,Narcotic Antagonist,Opioid Antagonist,Opioid Antagonists,Opioid Receptor Antagonist,Opioid Reversal Agent,Competitive Opioid Antagonists,Opioid Receptor Antagonists,Opioid Reversal Agents,Agent, Opioid Reversal,Agents, Opioid Reversal,Antagonist, Competitive Opioid,Antagonist, Narcotic,Antagonist, Opioid,Antagonist, Opioid Receptor,Antagonists, Competitive Opioid,Antagonists, Narcotic,Antagonists, Opioid,Antagonists, Opioid Receptor,Opioid Antagonist, Competitive,Opioid Antagonists, Competitive,Receptor Antagonist, Opioid,Receptor Antagonists, Opioid,Reversal Agent, Opioid,Reversal Agents, Opioid
D010880 Piperidines A family of hexahydropyridines.
D011957 Receptors, Opioid Cell membrane proteins that bind opioids and trigger intracellular changes which influence the behavior of cells. The endogenous ligands for opioid receptors in mammals include three families of peptides, the enkephalins, endorphins, and dynorphins. The receptor classes include mu, delta, and kappa receptors. Sigma receptors bind several psychoactive substances, including certain opioids, but their endogenous ligands are not known. Endorphin Receptors,Enkephalin Receptors,Narcotic Receptors,Opioid Receptors,Receptors, Endorphin,Receptors, Enkephalin,Receptors, Narcotic,Receptors, Opiate,Endorphin Receptor,Enkephalin Receptor,Normorphine Receptors,Opiate Receptor,Opiate Receptors,Opioid Receptor,Receptors, Normorphine,Receptors, beta-Endorphin,beta-Endorphin Receptor,Receptor, Endorphin,Receptor, Enkephalin,Receptor, Opiate,Receptor, Opioid,Receptor, beta-Endorphin,Receptors, beta Endorphin,beta Endorphin Receptor,beta-Endorphin Receptors
D002211 Capsaicin An alkylamide found in CAPSICUM that acts at TRPV CATION CHANNELS. 8-Methyl-N-Vanillyl-6-Nonenamide,Antiphlogistine Rub A-535 Capsaicin,Axsain,Capsaicine,Capsicum Farmaya,Capsidol,Capsin,Capzasin,Gelcen,Katrum,NGX-4010,Zacin,Zostrix,8 Methyl N Vanillyl 6 Nonenamide,NGX 4010,NGX4010
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D000094942 Nociceptin Receptor A member of the opioid subfamily of the G PROTEIN-COUPLED RECEPTORS. It is the receptor for the endogenous neuropeptide nociceptin. It functions in modulating NOCICEPTION and the perception of pain. KOR-3 Protein,Kappa3-Related Opioid Receptor,MOR-C Protein,Nociceptin Receptors,OFQ Receptor,OFQ Receptors,ORL1 Receptor,ORL1 Receptors,Opiate Receptor-Like 1,Opioid Receptor-Like Protein,Opioid-Receptor-Like 1 Protein,Orphanin FQ Receptor,Orphanin FQ Receptors,Receptor, Nociceptin,Receptor, OFQ,Receptor, Orphanin FQ,Receptors, ORL1,Noci-R,1 Protein, Opioid-Receptor-Like,1, Opiate Receptor-Like,FQ Receptor, Orphanin,FQ Receptors, Orphanin,MOR C Protein,Noci R,Opioid Receptor Like 1 Protein,Protein, KOR-3,Protein, MOR-C,Protein, Opioid Receptor-Like,Protein, Opioid-Receptor-Like 1,Receptor, Kappa3-Related Opioid,Receptor-Like 1, Opiate,Receptor-Like Protein, Opioid,Receptors, Nociceptin,Receptors, Orphanin FQ
D000097629 Nociceptin A pronociceptive peptide that acts as a specific endogenous agonist to the NOCICEPTIN RECEPTOR. N-OFQ Peptide,Nociceptin-Orphanin FQ,Orphanin FQ

Related Publications

M R Corboz, and M A Rivelli, and R W Egan, and D Tulshian, and J Matasi, and A B Fawzi, and L Benbow, and A Smith-Torhan, and H Zhang, and J A Hey
July 2001, Life sciences,
M R Corboz, and M A Rivelli, and R W Egan, and D Tulshian, and J Matasi, and A B Fawzi, and L Benbow, and A Smith-Torhan, and H Zhang, and J A Hey
December 2000, Autonomic neuroscience : basic & clinical,
M R Corboz, and M A Rivelli, and R W Egan, and D Tulshian, and J Matasi, and A B Fawzi, and L Benbow, and A Smith-Torhan, and H Zhang, and J A Hey
April 1990, Journal of applied physiology (Bethesda, Md. : 1985),
M R Corboz, and M A Rivelli, and R W Egan, and D Tulshian, and J Matasi, and A B Fawzi, and L Benbow, and A Smith-Torhan, and H Zhang, and J A Hey
January 1995, Respiration; international review of thoracic diseases,
M R Corboz, and M A Rivelli, and R W Egan, and D Tulshian, and J Matasi, and A B Fawzi, and L Benbow, and A Smith-Torhan, and H Zhang, and J A Hey
January 1992, Respiration; international review of thoracic diseases,
M R Corboz, and M A Rivelli, and R W Egan, and D Tulshian, and J Matasi, and A B Fawzi, and L Benbow, and A Smith-Torhan, and H Zhang, and J A Hey
January 1988, Pulmonary pharmacology,
M R Corboz, and M A Rivelli, and R W Egan, and D Tulshian, and J Matasi, and A B Fawzi, and L Benbow, and A Smith-Torhan, and H Zhang, and J A Hey
July 1989, Neuroscience letters,
M R Corboz, and M A Rivelli, and R W Egan, and D Tulshian, and J Matasi, and A B Fawzi, and L Benbow, and A Smith-Torhan, and H Zhang, and J A Hey
January 1991, Journal of lipid mediators,
M R Corboz, and M A Rivelli, and R W Egan, and D Tulshian, and J Matasi, and A B Fawzi, and L Benbow, and A Smith-Torhan, and H Zhang, and J A Hey
May 1990, Acta physiologica Scandinavica,
M R Corboz, and M A Rivelli, and R W Egan, and D Tulshian, and J Matasi, and A B Fawzi, and L Benbow, and A Smith-Torhan, and H Zhang, and J A Hey
January 1999, Life sciences,
Copied contents to your clipboard!